Ornate Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 04-01-2025
- Paid Up Capital ₹ 1.50 M
as on 04-01-2025
- Company Age 36 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 7.69 M
as on 04-01-2025
- Revenue 22.62%
(FY 2022)
- Profit 31.22%
(FY 2022)
- Ebitda 512.58%
(FY 2022)
- Net Worth 39.04%
(FY 2022)
- Total Assets -3.81%
(FY 2022)
About Ornate Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.50 M.
The company has closed loans amounting to ₹7.69 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Ankit Patel and Akash Patel serve as directors at the Company.
- CIN/LLPIN
U24231GJ1988PTC011476
- Company No.
011476
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Nov 1988
- Date of AGM
18 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Ornate Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ankit Patel  | Director | 06-Feb-2018 | Current |
| Akash Patel | Director | 08-Mar-2018 | Current |
Financial Performance of Ornate Pharma.
Ornate Pharma Pvt Ltd, for the financial year ended 2022, experienced significant growth in revenue, with a 22.62% increase. The company also saw a substantial improvement in profitability, with a 31.22% increase in profit. The company's net worth Soared by an impressive increase of 39.04%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ornate Pharma?
In 2021, Ornate Pharma had a public holding of 45.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 30 Dec 2020 | ₹5.00 M | Satisfied |
The Social Co-Op. Bank Ltd. Creation Date: 19 Mar 1996 | ₹0.90 M | Satisfied |
The Social Co-Op Bank Ltd. Creation Date: 20 Dec 1995 | ₹0.04 M | Satisfied |
How Many Employees Work at Ornate Pharma?
Ornate Pharma has a workforce of 3 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ornate Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ornate Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
